Found: 2
Select item for more details and to access through your institution.
Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer.
- Published in:
- International Journal of Biological Sciences, 2024, v. 20, n. 2, p. 486, doi. 10.7150/ijbs.86303
- By:
- Publication type:
- Article
Combined treatment of disulfiram with PARP inhibitors suppresses ovarian cancer.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1154073
- By:
- Publication type:
- Article